New capsule trial targets severe eczema itch and rash
NCT ID NCT07344051
Summary
This study is testing whether QLS12010 capsules can reduce skin inflammation and itching in adults with moderate-to-severe atopic dermatitis (eczema). 160 participants will receive either the active capsules or placebo pills for 16 weeks, with researchers measuring changes in rash severity and itch intensity. The goal is to determine if this oral treatment is effective and safe for controlling eczema symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.